Cannabidiol (CBD) is that portion of the cannabis plant which will not get you “high’’ unlike the THC part of the plant. It is normally used for health purposes rather than recreational purposes. The CDB products are extracted from either marijuana plants or industrial hemp plants. There are a number of excellent companies selling these products such as HempMeds RSHO Real Scientific Hemp Oil CBD but is also a proliferation of fly-by-night operators jumping on the bandwagon to take advantage of the substantial public interest in the substance
According to The Hemp Business Journal, by the year 2020 the market for CDB will increase to about $2.1 billion in consumer sales, and out of those sales, about $450 are derived from sources that are hemp-based which is a 700% growth from that which was recorded in 2016. As at 2015, there was a $90 million market for consumer sales of CDB products that are hemp-derived, with another $112 million worth of CBD products derived from marijuana sold through different dispensaries bringing the entire CDB market to about $202 million in the previous year.
There are also indications that normal marijuana users are not averse to trying CBD. Southern California’s biggest licensed cultivator discovered that 38% of both users and non-users expressed their desire to be better informed about CDB oil. Apart from predictions about the rapid growth of the market, a lot of insiders in the industry have already started to target the market. The Headset Research data showed that there are more than 800 CBD products flooding the market in just Washington State. This makes it challenging for customers to differentiate CBD products when trying to buy. An excellent source for evaluating products is the popular CBD oil reviews site called CBDReVu.com. Furthermore, though it has being suggested that CBD products improve different health problems, they cannot really substantiate those claims. And most of their product labels are intentionally vague on details, which make it very difficult for a customer to decide what to buy.
The government’s attitude towards CBD is not straight forward either. They are quite vague as far as oversight of these products is concerned. The Controlled Substance Act did not explicitly define CBD, however in 2003, the Drug Enforcement Agency (DEA) believing it to be a Schedule 1 controlled substance and sued the Hemp Association in court. But they lost. The Controlled Substance Act, or CSA, was amended by the Industrial Hemp Farming Act of 2015 in other to exclude hemp as well as other hemp-based CBD.
